Low-Dose Excimer 308-nm Laser for the Treatment of Oral Lichen Planus

Archives of Dermatology

Volumn 140, Issue 4, 2004, Pages 415-420

  Trehan, Manju ^a   Taylor, Charles R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; DISEASE SEVERITY; DYSPAREUNIA; EXCIMER LASER; FEMALE; HALITOSIS; HEPATITIS C; HUMAN; LICHEN PLANUS; MALE; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; PILOT PROJECTS; PROBABILITY; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 1842736577     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.140.4.415     Document Type: Article

References (56)

1. Cribier B, Frances C, Chosidow O. Treatment of lichen planus: an evidence-based medicine analysis of efficacy. Arch Dermatol. 1998;134:1521-1530.
2. Scully C, Eisen D, Carrozzo M. Management of oral lichen planus. Am J Clin Dermatol. 2000;1:287-306.
3. McCreary CE, McCartan BE. Clinical management of oral lichen Planus. Br J Oral Maxillofac Surg. 1999;37:338-343.
4. Lozada F, Silverman S Jr. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases. Arch Dermatol. 1980;116:898-901.
5. Chan ES, Thornhill M, Zakrzewska J. Interventions for treating oral lichen planus. Cochrane Database Syst Rev. 2000;2.
6. Muzio LL, della Valle A, Mignogna MD, et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations. J Oral Pathol Med. 2001;30:611-617.
7. Buajeeb W, Pobrurksa C, Kraivaphan P. Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;89:42-45.
8. Demitsu T, Sato T, Inoue T, Okada O, Kubota T. Corticosteroid-resistant erosive oral lichen planus successfully treated with topical cyclosporine therapy. Int J Dermatol. 2000;39:79-80.
9. Ho VC, Gupta AK, Ellis CN, Nickoloff BJ, Voorhees JJ. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol. 1990;22:64-68.
10. Harpenau LA, Plemons JM, Rees TD. Effectiveness of a low dose of cyclosporine in the management of patients with oral erosive lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:161-167.
11. Walchner M, Messer G, Salomon N, Plewig G, Rocken M. Topical tetracycline treatment of erosive oral lichen planus. Arch Dermatol. 1999;135:92-93.
12. Eisen D. Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: an open trial. J Am Acad Dermatol. 1993;28:609-612.
13. De Argila D, Gonzalo A, Pimentel J, Rovira I. Isolated lichen planus of the lip successfully treated with chloroquine phosphate. Dermatology. 1997;195:284-285.
14. Camisa C, Allen CM. Treatment of oral erosive lichen planus with systemic isotretinoin. Oral Surg Oral Med Oral Pathol. 1986;62:393-396.
15. Kaliakatsou F, Hodgson TA, Lewsey JD, Hegarty AM, Murphy AG, Porter SR-Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol. 2002;46:35-41.
16. Rozycki TW, Rogers RS III, Pittelkow MR, et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus. J Am Acad Dermatol. 2002;46:27-34.
17. Falk DK, Latour DL, King LE Jr. Dapsone in the treatment of erosive lichen planus. J Am Acad Dermatol. 1985;12:567-570.
18. Beck HI, Brandrup F. Treatment of erosive lichen planus with dapsone. Acta Dermatol Venereol. 1986;66:366-367.
19. Bogaert H, Sanchez E. Lichen planus: treatment of thirty cases with systemic and topical phenytoin. Int J Dermatol. 1990;29:157-158.
20. Lear JT, English JS. Erosive and generalized lichen planus responsive to azathioprine. Clin Exp Dermatol. 1996;21:56-57.
21. Verma KK, Mittal R, Manchanda Y. Azathioprine for the treatment of severe erosive oral and generalized lichen planus. Acta Dermatol Venereol. 2001;81:378-379.
22. Sun A, Chia JS, Chang YF, Chiang CP. Serum interleukin-6 level is a useful marker in evaluating therapeutic effects of levamisole and Chinese medicinal herbs on patients with oral lichen planus. J Oral Pathol Med. 2002;31:196-203.
23. Lu SY, Chen WJ, Eng HL. Dramatic response to levamisole and low-dose prednisolone in 23 patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80:705-709.
24. Popovsky JL, Camisa C. New and emerging therapies for diseases of the oral cavity. Dermatol Clin. 2000;18:113-125.
25. Becherel PA, Bussel A, Chosidow O, Rabian C, Piette JC, Frances C. Extracorporeal photochemotherapy for chronic erosive lichen planus. Lancet. 1998;351: 805.
26. Lundquist G, Forsgren H, Gajecki M, Emtestam L. Photochemotherapy of oral lichen planus: a controlled study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;79:554-558.
27. Kuusilehto A, Lehtinen R, Happonen RP, Heikinheimo K, Lehtimaki K, Jansen CT. An open clinical trial of a new mouth-PUVA variant in the treatment of oral lichenoid lesions. Oral Surq Oral Med Oral Pathol Oral Radiol Endod. 1997;84: 502-505.
28. Dereure O, Basset-Seguin N, Guilhou JJ. Erosive lichen planus: dramatic response to thalidomide. Arch Dermatol. 1996;132:1392-1393.
29. Gardner-Medwin JM, Smith NJ, Powell RJ, Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behcet's disease. Ann Rheum Dis. 1994;53:828-832.
30. Naafs B, Faber WR. Thalidomide therapy: an open trial. Int J Dermatol. 1985;24: 131-134.
31. Aufdemorte TB, De Villez RL, Gieseker DR. Griseofulvin in the treatment of three cases of oral erosive lichen planus. Oral Surg Oral Med Oral Pathol. 1983;55: 459-462.
32. Lener EV, Brieva J, Schachter M, West LE, West DP, el-Azhary RA. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol. 2001; 137:419-422.
33. Yoke PC, Machin D. Photochemotherapy of oral lichen planus [letter]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:2-4.
34. Lehtinen R, Happonen RP, Kuusilehto A, Jansen C. A clinical trial of PUVA treatment in oral lichen planus. Proc Finn Dent Soc. 1989;85:29-33.
35. Tanew A, Radakovic-Fijan S, Schemper M, Honigsmann H. Narrowband UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis: a paired comparison study. Arch Dermatol. 1999;135:519-524.
36. Barbagallo J, Spann CT, Tutrone WD, Weinberg JM. Narrowband UVB phototherapy for the treatment of psoriasis. Cutis. 2001;68:345-347.
37. Van Weelden H BdlfH, Young E, Van der Leun JC. Comparison of narrow band UVB phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Dermatol Venereol. 1990;70:212-215.
38. Anderson RR. Lasers in dermatology: a critical update. J Dermatol. 2000;27: 700-705.
39. Asawanonda P, Anderson RR, Chang Y, Taylor CR. 308-nm excimer laser for the treatment of psoriasis. Arch Dermatol. 2000;136:619-624.
40. Bonis B, Kemeny L, Dobozy A, Bor Z, Szabo G, Ignacz F. 308 nm UVB excimer laser for psoriasis. Lancet. 1997;350:1522.
41. Trehan M, Taylor CR. High-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol. 2002;46:732-737.
42. Plewig G, Jansen T, Jungblut RM, Roher HD. Castleman tumor, lichen ruber and pemphigus vulgaris? [in German]. Hautarzt. 1990;41:662-670.
43. Bowen GM, Peters NT, Fivenson DP, et al. Lichenoid dermatitis in paraneoplastic pemphigus. Arch Dermatol. 2000;136:652-656.
44. Helm TN, Camisa C, Liu AY, Valenzuela R, Bergfeld WF. Lichen planus associated with neoplasia. J Am Acad Dermatol. 1994;30:219-224.
45. Jansen T, Plewig G, Anhalt GJ. Paraneoplastic pemphigus with clinical features of erosive lichen planus associated with Castleman's tumor. Dermatology. 1995; 190:245-250.
46. Katta R. Lichen planus. Am Fam Phys. 2000;61:3319-3324, 3327-338.
47. Mignogna MD, Lo Muzio L, Favia G, Mignogna RE, Carbone R, Bucci E. Oral lichen planus and HCV infection. Int J Dermatol. 1998;37:575-578.
48. Mignogna MD, Lo Muzio L, Lo Russo L, Fedele S, Ruoppo E, Bucci E. Oral lichen planus: different clinical features in HCV-positive and HCV-negative patients. Int J Dermatol. 2000;39:134-139.
49. Nagao Y, Sata M, Abe K, Tanikawa K, Kameyama T. Immunological evaluation in oral lichen planus with chronic hepatitis C. J Gastroenterol. 1997;32:324-329.
50. Dupond AS, Lacour JP, Lafont C, Ortonne JP. Prevalence of hepatitis C virus in oral erosive lichen. Ann Dermatol Venereol. 1998;125:676-678.
51. Lodi G, Porter SR, Scully C. Hepatitis C virus infection: review and implications for the dentist. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:8-22.
52. Valente G, Pagano M, Carrozzo M, et al. Sequential immunohistochemical p53 expression in biopsies of oral lichen planus undergoing malignant evolution. J Oral Pathol Med. 2001;30:135-140.
53. Podskochy A, Gan L, Fagerholm P. Apoptosis in UV-exposed rabbit corneas. Cornea. 2000;19:99-103.
54. Washio F, Ueda M, Ito A, Ichihashi M. Higher susceptibility to apoptosis following ultraviolet B irradiation of xeroderma pigmentosum fibroblasts is accompanied by upregulation of p53 and downregulation of bcl-2. Br J Dermatol. 1999; 140:1031-1037.
55. Denfeld RW, Tesmann JP, Dittmar H, et al. Further characterization of UVB radiation effects on Langerhans cells. Photochem Photobiol. 1998;67:554-560.
56. Denfeld RW, Hara H, Tesmann JP, Martin S, Simon JC. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells. J Leukoc Biol. 2001;69:548-554.